Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PTIXW
- Price
- 0.00
- Stock movement up
- +- (%)
- Company name
- Protagenic Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- -
- Ent value
- -266.49K
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 46.00%
- 1 year return
- -97.54%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PTIXW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | -9.40 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -1.25 |
| FCF per share (TTM) | -0.93 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 28.34K |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -5.27M |
| Net income (TTM) | -5.65M |
| EPS (TTM) | -1.25 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | -18593.65% |
| Profit margin (TTM) | -19926.56% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.06M |
| Net receivables | 0.00 |
| Total current assets | 1.42M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 1.51M |
| Accounts payable | 108.64K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 789.32K |
| Total liabilities | 789.32K |
| Shareholder's equity | 719.01K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.54M |
| Capital expenditures (TTM) | 187.94K |
| Free cash flow (TTM) | -4.21M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -785.50% |
| Return on Assets | -374.44% |
| Return on Invested Capital | -785.50% |
| Cash Return on Invested Capital | -586.13% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.00 |
| Daily high | 0.00 |
| Daily low | 0.00 |
| Daily Volume | 1K |
| All-time high | 0.75 |
| 1y analyst estimate | - |
| Beta | 0.25 |
| EPS (TTM) | -1.25 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PTIXW | S&P500 | |
| Current price drop from All-time high | -99.79% | -14.41% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -71.81% | -11.07% |
| Avg time to new high | 34 days | 12 days |
| Max time to new high | 439 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Employees
1
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner